WaferiX

In print this week

Why are investors cool to the stocks of these two innovative medtech firms?

SINGAPORE (Aug 26): iX Biopharma is a small Catalist-listed Singapore company focusing on a big goal: Developing pain management drugs that are an alternative to opioids, and the optimum system to deliver these drugs into the body.

South Korea grants patent to iX Biopharma's technology

SINGAPORE (June 9): South Korea is the latest country to grant a patent to iX Biopharma’s WaferiX drug delivery technology, says the pharmaceutical firm on Thursday.
  •  
×